Multicenter phase 2 study of belotecan, a new camptothecin analog, and cisplatin-naive patients with extensive-disease small cell lung cancer (Cancer (2009) 116, (132-136))

D. H. Lee, S. W. Kim, C. Suh, J. S. Lee, J. S. Ahn, M. J. Ahn, K. Park, I. I. Na, J. C. Lee, B. Y. Ryoo, S. H. Yang

Research output: Contribution to journalComment/debatepeer-review

Fingerprint

Dive into the research topics of 'Multicenter phase 2 study of belotecan, a new camptothecin analog, and cisplatin-naive patients with extensive-disease small cell lung cancer (Cancer (2009) 116, (132-136))'. Together they form a unique fingerprint.